Drug shortages, the Pharmaceutical industry as a partner
- At: 2012 FIP Congress in Amsterdam (the Netherlands)
- Type: Presentation
- By: TELLNER, Pär (EFPIA, Regulatory Affairs, Brussels, Belgium)
When discussing drug shortages it is important to define what constitutes a drug shortage. Sometimes when a drug is not available in the market, it is because the healthcare provider cannot afford it. In certain smaller markets in e.g. Europe regulatory requirements for national language on the pack labels, make companies to decide not to have a.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.